Valuation: CelLBxHealth plc

Market Cap 14.49M 19.28M 16.96M 15.75M 27.17M 1.87B 27.66M 188M 73.48M 911M 72.39M 70.82M 3.16B P/E 2026 *
-0.55x
P/E 2027 * -14.2x
Enterprise Value 12.89M 17.15M 15.09M 14.01M 24.17M 1.66B 24.6M 168M 65.37M 810M 64.39M 63M 2.81B EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.42x
Free-Float
94.31%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CelLBxHealth plc

1 week-5.56%
Current month-16.39%
1 month-8.93%
3 months+30.77%
6 months+18.60%
Current year+15.91%
1 week 1.2
Extreme 1.2
1.35
1 month 1.2
Extreme 1.2
1.67
Current year 0.85
Extreme 0.85
2.8
1 year 0.85
Extreme 0.85
8
3 years 0.85
Extreme 0.85
37.4
5 years 0.85
Extreme 0.85
163.75
10 years 0.85
Extreme 0.85
163.75
Manager TitleAgeSince
Director of Finance/CFO - 01/01/1999
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Tech/Sci/R&D Officer - 05/06/2023
Director TitleAgeSince
Chairman 67 22/05/2023
Director/Board Member 61 12/01/2026
Director/Board Member 61 12/01/2026
Date Insider Type Main position Quantity % Market Cap.
19/12/25 Buy

Chairman

5,000,000 1.5497%
19/12/25 Buy

Chief Executive Officer

5,000,000 1.5497%
19/12/25 Buy

Chief Financial Officer

2,500,000 0.7749%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.56%-77.83%-91.50% 19.38M
+0.23%-10.35%+15.85%-36.63% 15.8B
+9.95%+3.06%+10.99%+115.26% 1.63B
-0.60%-9.05%-35.08%-80.94% 1.14B
-4.66%-5.73%-37.45%+10.63% 1.01B
+0.57%-4.41%-30.13%-53.93% 627M
+2.48%-7.99%-46.66%-56.93% 505M
+0.56%-0.65%+41.42%-53.79% 449M
-2.94%-6.16%-55.92%-62.88% 372M
-2.25%+2.66%-19.47%-39.30% 350M
Average +0.33%-1.65%-23.43%-35.00% 2.19B
Weighted average by Cap. +0.66%-7.21%+6.29%-27.32%

Financials

2026 *2027 *
Net sales 21.65M 28.81M 25.34M 23.54M 40.6M 2.79B 41.33M 281M 110M 1.36B 108M 106M 4.72B 37.75M 50.24M 44.18M 41.04M 70.79M 4.86B 72.06M 491M 191M 2.37B 189M 185M 8.23B
Net income -8.55M -11.38M -10.01M -9.3M -16.03M -1.1B -16.32M -111M -43.36M -537M -42.71M -41.79M -1.86B -1.85M -2.46M -2.17M -2.01M -3.47M -238M -3.53M -24.05M -9.38M -116M -9.24M -9.04M -403M
Net Debt -1.6M -2.13M -1.87M -1.74M -3M -206M -3.05M -20.8M -8.11M -101M -7.99M -7.82M -349M 1.4M 1.86M 1.64M 1.52M 2.63M 180M 2.67M 18.2M 7.1M 88M 6.99M 6.84M 305M
Logo CelLBxHealth plc
Cellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
Employees
114
Date Price Change Volume
23/07/26 GBX 1.275 0.00% 563,815
22/07/26 GBX 1.275 0.00% 346,152
21/07/26 GBX 1.275 +2.00% 512,783
20/07/26 GBX 1.250 0.00% 384,599
17/07/26 GBX 1.250 0.00% 894,293
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0128GBP
Average target price
0.0400GBP
Spread / Average Target
+213.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLBX Stock